ellipticine has been researched along with Alzheimer Disease in 1 studies
ellipticine : A organic heterotetracyclic compound that is pyrido[4,3-b]carbazole carrying two methyl substituents at positions 5 and 11.
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Le-Nhat-Thuy, G | 1 |
| Nguyen Thi, N | 1 |
| Pham-The, H | 1 |
| Dang Thi, TA | 1 |
| Nguyen Thi, H | 1 |
| Nguyen Thi, TH | 1 |
| Nguyen Hoang, S | 1 |
| Nguyen, TV | 1 |
1 other study available for ellipticine and Alzheimer Disease
| Article | Year |
|---|---|
Synthesis and biological evaluation of novel quinazoline-triazole hybrid compounds with potential use in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amino Acid Sequence; Catalytic Domain; Cholinesterase Inhib | 2020 |